PubMed Health⌕ Search

Biomedical subjects

R J Durbin

Publications and source records attributed to R J Durbin.

8 recordsLinked to original sources

Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance.

AIM: The second-generation thiazolidinediones (TZDs), rosiglitazone and pioglitazone, significantly decrease fasting plasma glucose and glycosylated haemoglobin (HbA(1c)) levels in patients with diabetes. Recent studies suggest that early treatment with TZDs may prevent the progression from insulin resistance (IR) to type 2 diabetes mellitus (T2DM). This prospective analysis examined the effect of early TZD treatment in the prevention or delay of T2DM in a multiethnic population with impaired glucose tolerance (IGT) and IR. METHODS: The analysis included 172 patients (aged 29-86 years) with IGT and IR (normal or borderline HbA(1c), C-peptide levels > 2 mg/ml, fasting blood sugar 100-125 mg/dl, and 2-h postprandial blood glucose levels 140-200 mg/dl). Patients in the active treatment group (n = 101) had received troglitazone for an average of 10 months before being randomly switched to rosiglitazone (4 mg/day) or pioglitazone (30 mg/day). Patients were switched when troglitazone was withdrawn from the US market because of liver toxicity concerns. Patients with IGT and IR who received no antidiabetic medication served as a control group (n = 71). HbA(1c) and C-peptide levels were measured at baseline (2 years) and study end point (3 years). Kaplan-Meier testing, using time to outcome as the main outcome variable, determined risk reduction in the TZD group relative to the control group. RESULTS: Mean HbA(1c) and C-peptide levels decreased for patients receiving either TZD at the 2-year assessment, and reductions were maintained at study end point. After 2 years, none of the patients receiving TZD therapy progressed to T2DM; three patients progressed to T2DM by study end point. In the control group, 11 patients became diabetic after 2 years and 19 patients became diabetic by the end of the study. The incidence (risk reduction) of diabetes after 3 years was 88.9% lower in the TZD group compared with the control group (p < 0.001). CONCLUSIONS: The TZDs, rosiglitazone and pioglitazone, were effective in reducing HbA(1c) and C-peptide levels in patients with IGT/IR. Progression of IR/IGT to T2DM appears to be significantly delayed or prevented with early TZD treatment.

Adult↗

Exercise program for wheelchair activity.

Poor physical fitness of wheelchair-dependent individuals may result in excessive cardiorespiratory responses during locomotion. The purpose of this study was to develop and implement an interval training program (ITP) incorporating wheelchair ergometer (WERG) exercise to improve fitness for wheelchair activity. Of thirteen able-bodied female volunteers, seven were selected to participate in a 5-week ITP, while the remainder served as sedentary controls. Both the exercise training (ET) group and the sedentary control (SC) group completed a standardized fitness test on the WERG before (pre-test) and after (post-test) the 5-week period. Following the ITP, submaximal heart rate, pulmonary ventilation and oxygen uptake responses of the ET group were generally found to be significantly lower during the post-test. These improvements in WERG exercise performance were not observed in the SC group. The ITP may have contributed to adaptations of upper body muscles, improved cardiorespiratory function, and/or a higher level of skill for wheelchair propulsion. We conclude that applying the concepts of interval training to wheelchair exercise may substantially improve the performance and fitness characteristics of wheelchair users. This could reduce the relative stresses of wheelchair locomotion and lead to a higher level of rehabilitation.

Adolescent↗

Evaluation of myocardial performance during wheelchair ergometer exercise.

Since a relatively high incidence of cardiovascular disease is associated with wheelchair confinement, exercise stress testing techniques should be utilized to assess myocardial performance of wheelchair-dependent individuals. Therefore, the purpose of this study was to apply the techniques of impedance cardiography to graded wheelchair-type exercise. For this, 9 wheelchair-dependent volunteers completed a progressive intensity, discontinuous test on a wheelchair ergometer (WERG) at power outputs (PO) of 10, 20, and 30 watts. An impedance cardiogram (ZCG), electrocardiogram (ECG), and phonocardiogram (PCG) were recorded for 15 sec immediately following steady state exercise. Stroke volume (delta V) calculated from the ZCG was multiplied by steady state heart rate (HR) to estimate cardiac output (Q). The simultaneous recording of the ZCG, ECG, and PCG permitted calculation of systolic time intervals and impedance cardiography contractility indices. Values for delta V, HR, Q, arteriovenous oxygen difference, systolic and diastolic blood pressure, mean systolic ejection rate, the first derivative of the impedance change, and the Heather Index increased with increments in PO. The Q-S2 interval, left ventricular ejection time (LVET), the pre-ejection period (PEP), the ratio of PEP to LVET, and the R-Z interval decreased with increases in exercise intensity. A linear relationship was found between Q and oxygen uptake which was similar to that reported by other investigators for arm exercise. These data indicate that impedance cardiography may be used in conjunction with electrocardiography and phonocardiography for the non-invasive assessment of myocardial performance during wheelchair exercise testing.

Adult↗